文献速递乳腺外科

放射性粒子定位与导丝定位治疗不可触及恶性乳腺疾病的随机单中心优效性试验

A Randomized, Single-Center, Superiority Trial of Radioactive Seed Localization Versus Wire Localization for Malignant Breast Disease.
PubMed 文献 · Ann Surg · 2024-05-24

该随机对照试验纳入400例不可触及恶性乳腺疾病女性,1:1分配至放射性粒子定位(RSL)或导丝定位(WL)。主要结局初始切除阴性切缘率无显著差异,但RSL在患者焦虑、疼痛及总体满意度方面评分更优,且放射科医生和外科医生认为其便利性和手术操作满意度更好;RSL成本高600美元。

要点

  • RSL与WL在初始切除阴性切缘率上无显著差异(P=0.29)。
  • RSL患者焦虑、疼痛及总体满意度评分均优于WL。
  • RSL较WL成本高600美元,放射科时间无差异。

核心结论

  • RSL可作为WL治疗不可触及恶性乳腺疾病的可接受替代方案。
  • RSL在阴性切缘率上未优于WL,但患者和提供者满意度更高。

研究设计与样本

  • 随机、单中心、优效性试验,2015年7月至2021年1月纳入400例不可触及恶性乳腺疾病女性,1:1随机分配至RSL或WL,按外科医生和浸润性疾病状态分层。
  • 主要结局为初始切除阴性切缘率,次要结局包括时间效率、成本和满意度。

主要发现

  • 阴性切缘率RSL 0.80(95%CI 0.75-0.86) vs WL 0.85(95%CI 0.80-0.89),P=0.29。
  • 患者焦虑评分OR=2.62(95%CI 1.79-3.84),P<0.01;疼痛OR=2.50(95%CI 1.69-3.71),P<0.01;总体满意度OR=3.24(95%CI 1.70-6.22),P<0.01,均 favoring RSL。
  • 放射科医生和外科医生认为RSL便利性OR=3.32(95%CI 1.65-6.69),P<0.01;手术操作满意度OR=1.67(95%CI 1.09-2.58),P=0.02。
  • 放射科时间RSL平均(SD)12.8±9.5分钟 vs WL 11.4±6.0分钟,P=0.18。
  • RSL较WL成本高600美元。

临床怎么用

  • 对于不可触及恶性乳腺疾病,RSL可作为WL的替代定位方法,尤其当患者满意度或操作便利性优先时。
  • 需考虑RSL较WL增加600美元成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Compare radioactive seed localization (RSL) and wire-guided localization (WL) for nonpalpable malignant breast disease. BACKGROUND: While WL has been the most common approach for localization of nonpalpable breast tumors, other techniques such as RSL, intraoperative ultrasound, radioactive intraoperative occult lesion localization, hematoma localization, radar localization, and magnetic seed localization have been suggested as safe and efficacious alternatives. However, very few randomized controlled trials have compared these localization techniques. METHODS: Between July 2015 and January 2021, 400 women with nonpalpable malignant breast disease were randomized 1:1 to RSL or WL, stratified by the surgeon and invasive disease status. The primary outcome was initial resection negative margin rates. Secondary outcomes included time efficiencies, cost, and satisfaction. RESULTS: There was no significant difference in negative margin rates between RSL and WL [RSL 0.80 (95% CI: 0.75-0.86) vs WL 0.85 (95% CI: 0.80-0.89); P=0.29]. RSL received better patient scores for anxiety [OR=2.62 (95% CI: 1.79-3.84); P<0.01], pain [OR=2.50 (95% CI: 1.69-3.71); P<0.01], and overall satisfaction [OR=3.24 (95% CI: 1.70-6.22); P<0.01] compared with WL. Radiologists and surgeons associated RSL with better convenience [OR=3.32 (95% CI: 1.65-6.69); P<0.01] and satisfaction of surgical procedure conduct [OR=1.67 (95% CI: 1.09-2.58); P=0.02]. Time in radiology did not differ [RSL mean (SD) 12.8±9.5 min vs. WL 11.4±6.0 min; P=0.18]. RSL incurred a $600 higher cost than WL. CONCLUSIONS: The results of the largest randomized controlled trial in the United States support RSL as an acceptable alternative to WL in the treatment of nonpalpable malignant breast disease. While RSL was not superior to WL in achievement of negative margins, patients and providers reported improved satisfaction scores.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Hadzikadic-Gusic L, Bilz J, Boselli D, et al. A Randomized, Single-Center, Superiority Trial of Radioactive Seed Localization Versus Wire Localization for Malignant Breast Disease. Ann Surg. 2024. PMID: 41220063. doi:10.1097/SLA.0000000000006356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。